BDBM717264 4-[3-(4-fluorophenyl)-1-(oxolan- 3-yl)-1H-pyrazol-4-yl]-6- phenylfuro[2,3-d]pyrimidine::US20250034159, Example 85

SMILES Fc1ccc(-c2nn(C3CCOC3)cc2-c2ncnc3oc(-c4ccccc4)cc23)cc1

InChI Key InChIKey=RCYCIRACLRYGOQ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 717264   

TargetEpidermal growth factor receptor [L858R,C797S](Human)
Oric Pharmaceuticals

US Patent
LigandPNGBDBM717264(4-[3-(4-fluorophenyl)-1-(oxolan- 3-yl)-1H-pyrazol-...)
Affinity DataIC50: 0.580nMAssay Description:The inhibitory activity of the compounds disclosed herein were measured in a biochemical assay utilizing a recombinant human EGFR L858R/C797S double ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor [1-18,20-1210,C797S](Human)
Oric Pharmaceuticals

US Patent
LigandPNGBDBM717264(4-[3-(4-fluorophenyl)-1-(oxolan- 3-yl)-1H-pyrazol-...)
Affinity DataIC50: 0.390nMAssay Description:The inhibitory activity of the compounds disclosed herein were measured in a biochemical assay utilizing a recombinant human EGFR exon 19 deletion/C7...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent